Evidence for the Presence of Borrelia Burgdorferi in Invasive Breast Cancer Tissues

April 9, 2024

https://www.researchgate.net/publication/378802154_Evidence_for_the_presence_of_Borrelia_burgdorferi_in_invasive_breast_cancer_tissues

Evidence for the presence of Borrelia burgdorferi in invasive breast cancer tissues

March 2024

DOI:10.1556/1886.2024.00021
Authors:  Niraj Jatin Patel, Sahaja Thippani, Jasmine Jathan, Gauri Gauri
Show all 7 authors
Download full-text PDF

Abstract

Borrelia burgdorferi , the causative agent of Lyme disease, has recently been demonstrated to infect and enhance the invasive properties of breast cancer cells, while also influencing the expression of inflammatory chemokines (CXCL8 and CXCL10). This study investigates the presence of B. burgdorferi in invasive breast cancer tissues using commercially available, FDA-approved breast cancer tissue microarrays consisting of 350 ductal, 32 lobular, and 22 intraductal invasive breast carcinomas, alongside 29 normal breast tissues. Employing fluorescent immunohistochemical staining and high-resolution imaging, the findings revealed that
  • approximately 20% of invasive lobular and ductal carcinomas, followed by
  • 14% of intraductal carcinomas, tested positive for B. burgdorferi,
  • while all normal breast tissues tested negative.
  • PCR analysis further confirmed the presence of B. burgdorferi DNA in breast cancer tissues.
  • Moreover, 25% of B. burgdorferi – positive tissues exhibited expression of both chemokines, CXCL8 and CXCL10, which was not observed in B. burgdorferi – negative tissues.
  • Analysis of available patient data, including age, indicated a correlation between older patients and B. burgdorferi – positive tissues.

This study validates the presence of B. burgdorferi in invasive breast cancer tissues and highlights the involvement of key CXCL family members associated with inflammatory processes.

_______________

**Comment**

It all of a sudden becomes quite clear why ‘the powers that be’ simply had to bury ivermectin and HCQ.  These drugs are turning out to be highly anti-viral and anti-cancer.  More and more is coming out on these safe, cheap drugs that have been effectively repurposed for cancer.  Due to a court order, the FDA had to remove its controversial verbiage on ivermectin from its website.  Predictably, the FDA claims no wrongdoing despite an estimated 500,000 deaths due to its suppression of ivermectin, as well as the fact doctors lost their jobs for simply endorsing the drug.

The FDA has a lot to answer for.

I also highly recommend reading and listening to this:  https://robertyoho.substack.com/p/302-how-to-save-your-life-if-you

On a personal side note relating to the above link: my holistic doctor (RIP) once told me that he successfully treated female cancers with testosterone and male cancers with estrogen.  At the time there weren’t any studies on this hormone approach for cancer and all he had to support it was his 35 years of clinical experience.  Now, it finally appears there are some studies:  https://hormonebalance.org/publications/

Another doctor we used has completely restored women who have severe endometriosis by using a cocktail of synthetic testosterones (nandrolone and stanozolol) that doesn’t break down into estrogen as well as the anti-androgen spironolactone to counter any facial hair or lowering of the voice.  My daughter still uses this treatment and it has worked amazingly for over ten years.  To say it has changed her life would be an understatement.

This too is a big reason hormone therapy is nearly banned in mainstream medicine.  It just does too many things for health which interferes with Big Pharma profits.

If you haven’t figured it out yet, the FDA could care less about true health.

For more:

Category:

Cancer, Inflammation, Lyme, research

Comments Off on Evidence for the Presence of Borrelia Burgdorferi in Invasive Breast Cancer Tissues